Oxlumo® Lumasiran Injection

Name: Small Interfering Ribonucleic Acid (siRNA) Treatment
Brand: Oxlumo®

OXLUMO, VL 94.5MG/0.5ML D/S

McKesson #

1181586

Manufacturer #

71336100201

Brand

Oxlumo®

Manufacturer

Alnylam Pharmaceuticals Inc

Country of Origin

Unknown

Application

Small Interfering Ribonucleic Acid (siRNA) Treatment

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Name

Lumasiran

NDC Number

71336100201

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Type

Subcutaneous

UNSPSC Code

41105515

OXLUMO® is an HAO1-directed small interfering ribonucleic acid (siRNA) indicated for the treatment of Primary Hyperoxaluria Type 1 (PH1) to lower the urinary oxalate levels in pediatric and adult patients. PH1 is an ultra-rare progressive genetic disease that can be potentially life-threatening.